Design and structure activity relationships of highly potent and bioavailable imidazolinone FASN KR domain inhibitors

被引：0

作者：

Bignan, G. ^{[1
]}

Alexander, R. ^{[1
]}

Bischoff, J. ^{[1
]}

Connolly, P. ^{[1
]}

Cummings, M. ^{[1
]}

De Breucker, S. ^{[2
]}

Esser, N. ^{[2
]}

Fraiponts, E. ^{[2
]}

Gilissen, R. ^{[2
]}

Grasberger, B. ^{[1
]}

Janssens, B. ^{[2
]}

Lu, T. ^{[1
]}

Ludovici, D. ^{[1
]}

Meerpoel, L. ^{[2
]}

Meyer, C. ^{[3
]}

Parker, M. ^{[1
]}

Peeters, D. ^{[2
]}

Rocaboy, C. ^{[4
]}

Schubert, C. ^{[1
]}

Smans, K. ^{[2
]}

机构：

[1] Janssen, Oncol, Spring House, PA USA

[2] Janssen, Oncol, Beerse, Belgium

[3] Janssen, Oncol, Val De Reuil, France

[4] VillaPharma Res, Chem, Murcia, Spain

来源：

EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷

关键词：

D O I：

10.1016/S0959-8049(14)70556-8

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

430

引用

页码：141 / 142

页数：2

共 50 条

[1] Design and synthesis of a series highly potent and bioavailable FASN KR domain inhibitors for cancer
Lu, Tianbao
Alexander, Richard
Bignan, Gilles
Bischoff, James
Connolly, Peter
Cummings, Max
De Breucker, Sabine
Esser, Norbert
Fraiponts, Erwin
Gilissen, Ron
Grasberger, Bruce
Janssens, Boudewijn
Ludovici, Donald
Meerpoel, Lieven
Meyer, Christophe
Parker, Michael
Peeters, Danielle
Schubert, Carsten
Smans, Karine
Van Nuffel, Luc
Vermeulen, Peter
CANCER RESEARCH, 2014, 74 (19)
[2] Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy
Lu, Tianbao
Schubert, Carsten
Cummings, Maxwell D.
Bignan, Gilles
Connolly, Peter J.
Smans, Karine
Ludovici, Donald
Parker, Michael H.
Meyer, Christophe
Rocaboy, Christian
Alexander, Richard
Grasberger, Bruce
De Breucker, Sabine
Esser, Norbert
Fraiponts, Erwin
Gilissen, Ron
Janssens, Boudewijn
Peeters, Danielle
Van Nuffel, Luc
Vermeulen, Peter
Bischoff, James
Meerpoel, Lieven
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (12) : 2159 - 2164
[3] Design, synthesis, and structure-activity relationships of the first highly potent, selective, and bioavailable adenosine5′-monophosphate deaminase inhibitors
Kasibhatla, SR
Bookser, BC
Appleman, JR
Probst, G
Xiao, W
Fujitaki, JM
Erion, MD
PURINE AND PYRIMIDINE METABOLISM IN MAN IX, 1998, 431 : 849 - 852
[4] Design, synthesis and structure-activity relationships of a series of novel and highly potent neutral inhibitors of factor Xa.
Zhu, BY
Jia, ZZJ
Zhang, PL
Huang, WR
Wang, LY
Goldman, E
Zuckett, JMF
Wu, YH
Su, T
Song, YH
Woolfrey, J
Huang, B
Wong, P
Sinha, U
Park, G
Hollenbach, S
Scarborough, RM
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 223 : A109 - A109
[5] Novel tetracyclic benzo[b]carbazolones as highly potent and orally bioavailable ALK inhibitors: Design, synthesis, and structure-activity relationship study
Jiang, Xiaolong
Zhou, Ji
Ai, Jing
Song, Zilan
Peng, Xia
Xing, Li
Xi, Yong
Guo, Junfeng
Yao, Qizheng
Ding, Jian
Geng, Meiyu
Zhang, Ao
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 105 : 39 - 56
[6] Structure Activity Relationships of Flavonoids as Potent α-Amylase Inhibitors
Yuan, Erdong
Liu, Benguo
Wei, Qingyi
Yang, Jiguo
Chen, Lei
Li, Qiong
NATURAL PRODUCT COMMUNICATIONS, 2014, 9 (08) : 1173 - 1176
[7] Structure-guided design of potent, selective, and orally bioavailable Tankyrase inhibitors
Bregman, Howard
DiMauro, Erin
Chakka, Nagasree
Guzman-Perez, Angel
Hua, Zihao
Huang, Hongbing
Martin, Matthew
Buchanan, John
Gunaydin, Hakan
Huang, Xin
Huang, Liyue
Wilson, Cindy
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[8] Design, synthesis and structure-activity relationships of potent B-RAF inhibitors
Namdev, Nivedita
Lapierre, Jean-Marc
Liu, Yanbin
Wu, Hui
Brassard, Chris
Westlund, Neil
Tandon, Manish
Link, Jeff
Kizer, Darin
Nicewonger, Robb
Bresciano, Karen
Hall, Terence
Szwaya, Jeff
Chen, Chang-Rung
France, Dennis
Ashwell, Mark A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
[9] Design and Preparation of Potent, Nonpeptidic, Bioavailable Renin Inhibitors
Bezencon, Olivier
Bur, Daniel
Weller, Thomas
Richard-Bildstein, Sylvia
Remen, Lubos
Sifferlen, Thierry
Corminboeuf, Olivier
Grisostomi, Corinna
Boss, Christoph
Prade, Lars
Delahaye, Stephane
Treiber, Alexander
Strickner, Panja
Binkert, Christoph
Hess, Patrick
Steiner, Beat
Fischli, Walter
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (12) : 3689 - 3702
[10] Lead optimization and structure-based design of potent and bioavailable deoxycytidine kinase inhibitors
Jessop, Theodore C.
Tarver, James E.
Carlsen, Marianne
Xu, Amy
Healy, Jason P.
Heim-Riether, Alexander
Fu, Qinghong
Taylor, Jerry A.
Augeri, David J.
Shen, Min
Stouch, Terry R.
Swanson, Ronald V.
Tari, Leslie W.
Hunter, Michael
Hoffman, Isaac
Keyes, Philip E.
Yu, Xuan-Chuan
Miranda, Maricar
Liu, Qingyun
Swaffield, Jonathan C.
Kimball, S. David
Nouraldeen, Amr
Wilson, Alan G. E.
Foushee, Ann Marie DiGeorge
Jhaver, Kanchan
Finch, Rick
Anderson, Steve
Oravecz, Tamas
Carson, Kenneth G.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (23) : 6784 - 6787

← 1 2 3 4 5 →